The effect of D-galactosamine on LCAT secretion and ultrastructure of isolated rat hepatocytes

Acta Pathologica Et Microbiologica Scandinavica. Section A, Pathology
G NordbyK R Norum

Abstract

The effect of D-galactosamine on secretory activity and morphology of isolated rat hepatocytes was investigated: Galactosamine was found to reduce the secretion of lipoproteins (as indicated by the release of free cholesterol and triacylglycerol) as well as the secretion of lecithin: cholesterol acyltransferase (LCAT) and [14C]-labelled proteins from the isolated cells. The secretion of LCAT was inhibited much more than that of the other secretory products studied. Transmission electron microscopy revealed that galactosamine induced morphological changes in RER, mitochondria and nucleoli. The most striking feature of galactosamine-treated hepatocytes, however, was the appearance of swollen lysosomes. Some of these organelles measured up to 3 mumicrometer in diameter. Uridine did not abolish the effect of galactoosamine upon the secretory activity of hepatocytes. The most conspicuous ultrastructural feature in cells that had been incubated with both uridine and galactosamine was the appearance of large amounts of glycogen. The possibility that galactosamine inhibits glycogenolysis is discussed. The rather selective effect of galactosamine on LCAT secretion suggests the use of this compound for the study of the interrelationship ...Continue Reading

References

Oct 21, 1976·Biochimica Et Biophysica Acta·G NordbyK R Norum
Jul 26, 1976·Biochemical and Biophysical Research Communications·S R WagleK Decker
Jul 26, 1976·Biochemical and Biophysical Research Communications·C F van BezooijenD L Knook
Jan 24, 1977·Biochimica Et Biophysica Acta·P O Seglen, A Reith
Feb 1, 1972·Experimental and Molecular Pathology·H ScharnbeckK Decker
Sep 15, 1974·Biochemical Pharmacology·C de DuveF Van Hoof
Apr 1, 1970·Experimental and Molecular Pathology·A MedlineH Popper

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.